The generic for the popular anti-depressant Wellbutrin XL is under investigation by the FDA after consumers complained of severe headaches, anxiety, insomnia and digestive ailments. The generic Budeprion XL was approved for use in 2006. A consumer products advocacy group ConsumerLab.com began testing the drug after the complaints arose. The tests revealed some differences in the scientific formulation of the drug from Wellbutrin. Other tests revealed that the generic Budeprion’s timed release formula actually released 4 times the amount of drug into the body in the same two hour period as Wellbutrin.
For more information on this subject, please refer to the section on Drugs, Medical Devices, and Implants.
Admitted to practice law in all federal multidistrict litigation courts, the California State Bar and the Florida Bar. His philosophy is to provide aggressive, quality representations and seek fair compensation for individuals and their families who have suffered injury, death, or sexual abuse.
Comments for this article are closed.